This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Diagnosis With Metrizamide Cisternography

William F. Young, Jr, MD; Luis F. Ospina, MD; David Wesolowski, MD; Alfred Touma, MD

JAMA. 1981;246(22):2611-2612.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

EMPTY sella syndrome occurs when the suprasellar subarachnoid space extends into the sella turcica. The primary syndrome presents in a patient with no prior history of pituitary radiation or surgery,¹ is benign, and requires no therapy unless there is progressive visual field loss, rhinorrhea, or an associated microadenoma.² The correct diagnosis is crucial to avoid unnecessary surgical or radiation therapy for a suspected intrasellar tumor. The radiological evaluation has recently improved with the use of intrathecal metrizamide (Amipaque) and computed tomography (CT).^3-5 This report presents a case of the primary empty sella syndrome with associated bitemporal visual field defects definitively diagnosed with metrizamide cisternography and correlative CT. Also, the endocrinologic presentation of this syndrome with associated visual field defects is further defined.

Report of a Case

A 32-year-old, healthy married woman had "floating spots" in her eyes for three years and recent onset of blurring vision. She . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Medicine, Division of Endocrinology (Drs Young and Ospina), Diagnostic Radiology (Dr Wesolowski), and Ophthalmology (Dr Touma), William Beaumont Hospital, Royal Oak, Mich.

Footnotes
Reprint requests to Department of Medicine, William Beaumont Hospital, 3601 W 13 Mile Rd, Royal Oak, MI 48072 (Dr Ospina).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?